Synthetic Biologics Inc (SYN) - Financial Analysis Review

Summary

Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals, Inc., which focuses on the development of novel therapeutics to treat gut microbiome. Its pipeline product portfolio includes SYN-010 and SYN-004. The companys SYN-010, a drug candidate which is intended to treat rritable bowel syndrome with constipation (IBS-C) and SYN-004 is used to prevent C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). Synthetic Biologicss develops preclinical monoclonal antibody therapies for the treatment of pertussis, and novel discovery stage biotherapeutics for the treatment of phenylketonuria.

GlobalData's Synthetic Biologics Inc (SYN) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Synthetic Biologics Inc Key Recent Developments:

Nov 01,2016: Synthetic Biologics Reports Third Quarter 2016 Operational Highlights and Financial Results
Aug 03,2016: Synthetic Biologics Reports Second Quarter 2016 Operational Highlights and Financial Results
May 09,2016: Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
May 05,2016: Synthetic Biologics Reports First Quarter 2016 Operational Highlights and Financial Results
Mar 10,2016: Synthetic Biologics Reports 2015 Year End Operational Highlights and Financial Results


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financi